Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paclitaxel Adverse Reaction”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)UnknownNCT00024310
What this trial is testing

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05310331
What this trial is testing

Donafenib for Recurrent Cervical Cancer

Who this might be right for
Targeted TherapyChemotherapyRecurrent Cervical Carcinoma+4 more
Lei Li 20
Large-scale testing (Phase 3)Study completedNCT00003313
What this trial is testing

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerOral Complications+1 more
Radiation Therapy Oncology Group 243
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableStudy completedNCT05093023
What this trial is testing

ABCB1 SNPs as Predictors of PIPN

Who this might be right for
Paclitaxel Adverse ReactionNeuropathy;PeripheralBreast Cancer
Ain Shams University 92
Testing effectiveness (Phase 2)Study completedNCT00387374
What this trial is testing

Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab

Who this might be right for
Adenosquamous Cell Lung CancerDrug/Agent Toxicity by Tissue/OrganHemoptysis+3 more
National Cancer Institute (NCI) 72
Not applicableUnknownNCT02753036
What this trial is testing

Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer

Who this might be right for
Cognition DisordersPolyneuropathies
Charite University, Berlin, Germany 72
Testing effectiveness (Phase 2)UnknownNCT04635956
What this trial is testing

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Who this might be right for
ChemotherapyAnti-pd-1 AntibodyCervical Neuroendocrine Carcinoma+4 more
Lei Li 20
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Not applicableLooking for participantsNCT06387901
What this trial is testing

Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.

Who this might be right for
Breast CancerPaclitaxel Adverse ReactionChemotherapeutic Toxicity+3 more
Universitair Ziekenhuis Brussel 40
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Testing effectiveness (Phase 2)Study completedNCT00006012
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
Alliance for Clinical Trials in Oncology 73
Not applicableUnknownNCT04683458
What this trial is testing

Analysis of Linked Health Insurance Claims and Clinical Registries to Determine Device Surveillance With Paclitaxel-coated Medical Devices

Who this might be right for
Paclitaxel Adverse ReactionOutcome, Fatal
Universitätsklinikum Hamburg-Eppendorf 14,000
Not applicableStudy completedNCT04496544
What this trial is testing

Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)

Who this might be right for
Peripheral Arterial DiseasePaclitaxel Adverse ReactionSafety Issues
Beth Israel Deaconess Medical Center 168,553
Not applicableStudy completedNCT01797991
What this trial is testing

Comparison of Two Regimens of Dexamethasone in the Prevention of Hypersensitivity Reactions to Paclitaxel, a Pilot Study

Who this might be right for
Prevention of Hypersensitivity Reactions to Paclitaxel
Centre hospitalier de l'Université de Montréal (CHUM) 30
Testing effectiveness (Phase 2)UnknownNCT02024568
What this trial is testing

Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia

Who this might be right for
TaxaneDrug-related Side Effects and Adverse ReactionsPain+1 more
Assaf-Harofeh Medical Center 38
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Not applicableNot Yet RecruitingNCT06977594
What this trial is testing

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer
Seoul National University Hospital 1,000